首页> 美国卫生研究院文献>PLoS Clinical Trials >Retinoic Acid Increases Proliferation of Human Osteoclast Progenitors and Inhibits RANKL-Stimulated Osteoclast Differentiation by Suppressing RANK
【2h】

Retinoic Acid Increases Proliferation of Human Osteoclast Progenitors and Inhibits RANKL-Stimulated Osteoclast Differentiation by Suppressing RANK

机译:维甲酸增加人类破骨细胞祖细胞的增殖并通过抑制RANK抑制RANKL刺激的破骨细胞分化。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It has been shown that high vitamin A intake is associated with bone fragility and fractures in both animals and humans. However, the mechanism by which vitamin A affects bones is unclear. In the present study, the direct effects of retinoic acid (RA) on human and murine osteoclastogenesis were evaluated using cultured peripheral blood CD14+ monocytes and RAW264.7 cells. Both the activity of the osteoclast marker tartrate resistant acid phosphatase (TRAP) in culture supernatant and the expression of the genes involved in osteoclast differentiation together with bone resorption were measured. To our knowledge, this is the first time that the effects of RA on human osteoclast progenitors and mature osteoclasts have been studied in vitro. RA stimulated proliferation of osteoclast progenitors both from humans and mice. In contrast, RA inhibited differentiation of the receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclastogenesis of human and murine osteoclast progenitors via retinoic acid receptors (RARs). We also show that the mRNA levels of receptor activator of nuclear factor κB (RANK), the key initiating factor and osteoclast associated receptor for RANKL, were potently suppressed by RA in osteoclast progenitors. More importantly, RA abolished the RANK protein in osteoclast progenitors. This inhibition could be partially reversed by a RAR pan-antagonist. Furthermore, RA treatment suppressed the expression of the transcription factor nuclear factor of activated T-cells cytoplasmic 1 (NFATc1) and increased the expression of interferon regulatory factor-8 (IRF-8) in osteoclast progenitors via RARs. Also, RA demonstrated differential effects depending on the material supporting the cell culture. RA did not affect TRAP activity in the culture supernatant in the bone slice culture system, but inhibited the release of TRAP activity if cells were cultured on plastic. In conclusion, our results suggest that retinoic acid increases proliferation of human osteoclast progenitors and that it inhibits RANK-stimulated osteoclast differentiation by suppressing RANK.
机译:已经表明,高维生素A的摄入与动物和人类的骨骼脆弱性和骨折有关。但是,维生素A影响骨骼的机制尚不清楚。在本研究中,使用培养的外周血CD14 + 单核细胞和RAW264.7细胞评估了视黄酸(RA)对人和鼠破骨细胞形成的直接作用。测量了培养上清液中破骨细胞标志物酒石酸抗性酸性磷酸酶(TRAP)的活性以及破骨细胞分化和骨吸收相关基因的表达。据我们所知,这是首次在体外研究RA对人类破骨细胞祖细胞和成熟破骨细胞的作用。 RA刺激人和小鼠的破骨细胞祖细胞增殖。相反,RA通过视黄酸受体(RAR)抑制了核因子κB配体(RANKL)诱导的人和鼠破骨细胞祖细胞的破骨细胞生成。我们还显示,RA在破骨细胞祖细胞中有效抑制了核因子κB(RANK),RANKL的关键起始因子和破骨细胞相关受体的受体激活剂的mRNA水平。更重要的是,RA废除了破骨细胞祖细胞中的RANK蛋白。 RAR泛拮抗剂可部分逆转这种抑制作用。此外,RA治疗通过RAR抑制破骨细胞祖细胞中活化的T细胞细胞质1(NFATc1)转录因子核因子的表达,并增加了破骨细胞祖细胞中干扰素调节因子8(IRF-8)的表达。同样,RA显示出不同的作用,具体取决于支持细胞培养的材料。 RA不会影响骨切片培养系统中培养上清液中的TRAP活性,但是如果将细胞培养在塑料上,RA会抑制TRAP活性的释放。总之,我们的结果表明,视黄酸可增加人类破骨细胞祖细胞的增殖,并通过抑制RANK抑制RANK刺激的破骨细胞分化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号